News Products and Industry News

Educational program partnership established

HMP (Malvern, PA), a global leader in health care events and education, announced its new partnership with Daemen College (Buffalo, NY) in the Why Wound Care? initiative. The program educates nursing students, recent graduates, and nursing faculty about the rewarding careers in wound care. Daemen College nursing students and faculty will have access to free educational resources developed by professional wound care nurses, including 12 basic learning module PowerPoints about beginning a career in wound care, 4 advanced learning module PowerPoints for recent graduates and faculty to increase wound care knowledge, 2 interactive video modules, and all 25 chapters of Chronic Wound Care: The Essentials in a downloadable PDF format. The partnership will formally kick off in the college’s spring semester when select faculty share the opportunity with their nursing students.

For more information, visit www.prweb.com/releases/2017/12/prweb14986593.htm. 

Handheld wound imaging technology launched in Europe

Smith & Nephew (London, UK) announced the European launch of MolecuLight i:X (Toronto, ON, Canada), a handheld imaging device for assessing wounds. The product is an easy-to-use device that can quickly and accurately measure wound surface area as well as visualize the presence and distribution of potentially harmful bacteria. The imaging device is approved by Health Canada and has a CE Marking for sale in the European Union, although it is not currently available in the United States.

The European launch of the device comes after Smith & Nephew finalized an exclusive distribution agreement with the device’s manufacturer, MolecuLight, in May 2017.

For more information, visit www.smith-nephew.com/news-and-media/media-releases/news/european-launch-of-handheld-imaging-technology-heralds-new-era-of-evidence-based-decision-making/. 

Group purchasing agreement reached

A group purchasing agreement was reached between   AMNIOX Medical (Atlanta, GA), a TissueTech Inc (Doral, FL) company, and Premier Inc (Charlotte, NC) for regenerative skin grafting products. The agreement, effective January 1, 2018, allows Premier group members to use the full       AMNIOX portfolio at special prenegotiated terms. The portfolio includes both NEOX wound and CLARIX surgical solutions, which are processed with the company’s CRYOTEK cryopreservation technology for preserving biological and structural properties.

For more information, visit www.businesswire.com/news/home/20171211005683/en/AMNIOX-Medical-Awarded-Premier-Agreement-Regenerative-Medicine. 

International wound care certification available

Wound care professionals abroad will now be able to add Wound Care Certified (WCC) credentials thanks to an international expansion from the National Alliance of Wound Care and Ostomy (NAWCO; St Joseph, MI). The first group of candidates sat for a proctored board certification exam on December 8, 2017, after concluding an alliance-approved skin and wound management course in Nassau, the Bahamas.

The certification is a nationally recognized, voluntarily earned, multidisciplinary credential held by more than 22 000 professionals. The NAWCO expects to host additional international certification opportunities in 2018 with its partnership with the Wound Care Education Institute (Plainfield, IL).

For more information, visit https://www.prnewswire.com/news-releases/national-alliance-of-wound-care-and-ostomy-initiates-wound-care-certification-internationally-300568871.html. 

Wound healing technology secures exclusive license

XCell Biologix (Kennesaw, GA) obtained the exclusive license to a new cell-free treatment chronic wounds and burns developed at the Wake Forest Institute for Regenerative Medicine (WFIRM; Winston-Salem, NC). The treatment is derived from the placental amnion and can be applied to the skin in a powder, liquid, or spray form, making it a valuable tool to protect, heal, and repair wounds by accelerating wound closure and promoting skin growth.

The worldwide licensing agreement allows XCell Biologix to further develop and commercialize the technology in severe burn and chronic wound markets. In the meantime, WFIRM will complete the initial phase of development as well as a potential small group clinical study.

For more information, visit www.eurekalert.org/pub_releases/2017-12/wfbm-wwh121117.php. 

Agreements reached for wound care, incontinence

Medline (Northfield, IL) was awarded 2 new agreements with Resource Optimization & Innovation (ROi; St Louis, MO) through the latter’s Pre-Commitment Program. With the agreements, ROi members will be able to access a large portfolio of products related to traditional wound care and incontinence categories, including gauze, bandages, abdominal pads, underpads, and briefs. The ROi network currently includes more than 250 hospitals and 2800 nonacute care facilities in across the United States.

For more information, visit www.hmenews.com/also-noted/medline-roi-announce-agreements-wound-care-incontinence. 

Agreement reached for regenerative medicine application distribution

Axolotl Biologix (Phoenix, AZ) reached an agreement with AdiMarket (Miami Lakes, FL), a subsidiary of Global Stem Cells Group (Miami Lakes, FL), for worldwide distribution of its regenerative medicine applications. Products from the Phoenix-based company that will be available through the subsidiary’s online store include AxoBioFluid C, a cryopreserved liquid amniotic allograft for the replacement of soft tissue, and AxoBioMembrane, a dehydrated amnion allograft for wound repair, skin replacement, and reconstruction.

For more information, visit www.digitaljournal.com/pr/3607016. 

New distributors acquired

Coloplast (Humlebæk, Denmark) recently acquired SAS Lilial (Saint-Barthélemy-d’Anjou, Fance) for cash consideration. The deal, valued at $35.5 million or KR 264 million, gives the Danish company control of the privately owned French company which distributes catheter and ostomy supplies from several different manufacturers. In 2016, the company, which bases its United States headquarters in Minneapolis (MN), bought Comfort Medical (Coral Springs, FL), a provider of ostomy, urology, continence and wound care supplies, for $160 million in cash.

For more information, visit www.hmenews.com/article/coloplast-buys-another-homecare-provider.

In addition, Navamedic ASA (Lysaker, Norway) announced its new distribution agreement with Chemviron Carbon Ltd (Feluy, Hainaut, Belgium) for Zorlex. The agreement would launch and commercialize the wound care contact dressing in Sweden and Finland, expanding the market for the naturally antimicrobial, 100% activated carbon wound contact dressing. The product is a highly absorbent dressing that accelerates the healing process by entrapping and eliminating microbes on the wound surface. Its flexible knitted design can be used with all wound types, including chronic and nonchronic venous leg, diabetic, and pressure ulcers; trauma wounds; surgical wounds; and fungal skin infections. The dressing has no added chemical agens and uses triple action (antimicrobial, conductivity, odor management) to help wounds heal faster.

For more information, visit https://globenewswire.com/news-release/2017/12/21/1268714/0/en/Navamedic-ASA-Enters-into-partnership-agreement-for-distribution-of-Zorflex-in-Sweden-and-Finland.html.